Skip to main content
Erschienen in: BMC Infectious Diseases 1/2018

Open Access 01.12.2018 | Research article

Gonorrhea and chlamydia prevalence in different anatomical sites among men who have sex with men: a cross-sectional study in Guangzhou, China

verfasst von: Li-Gang Yang, Xiao-Hui Zhang, Pei-Zhen Zhao, Zheng-Yu Chen, Wu-Jian Ke, Xu-Qi Ren, Liu-Yuan Wang, Wei-Ying Chen, Joseph D. Tucker

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2018

Abstract

Background

A high rectal and oropharyngeal sexually transmitted infection (STI) burden has been reported among men who have sex with men (MSM) in many regions, but little data exists on rectal and oropharyngeal STIs among MSM in China. The purpose of this study was to determine the prevalence of gonorrhea and chlamydia at different anatomic sites among MSM in Guangzhou, China.

Methods

We recruited a cross-sectional sample of MSM in one Chinese city and collected detailed information about socio-demographic characteristics and sexual behaviors. Men had urine, rectal, and pharyngeal swab samples tested for gonorrhea and chlamydia using nucleic acid amplification tests (NAAT). Univariate and multivariate logistic regressions were used to evaluate factors associated with gonorrhea and chlamydia. Among men without any STI symptoms, we also examined the prevalence of gonorrhea and chlamydia by anatomical site.

Results

We enrolled 463 men between January 2015 and March 2017. A total of 58/463 (12.5%) of men had gonorrhea and 84/463 (18.1%) had chlamydia. MSM with gonorrhea were more likely to have been recruited from the STI clinic (OR 3.41, 95% CI 1.94–5.99), living with HIV (OR 2.41, 95% CI 1.18–4.92), diagnosed had STI co-infection (OR 2.55, 95% CI 1.39–4.69). MSM with chlamydia were more likely to be students (OR 1.8, 95% CI 0.99–3.39). Most gonorrhea (34/58, 59%) and chlamydia (64/84, 76%) infections were not associated with STI symptoms.

Conclusion

Asymptomatic gonorrhea and chlamydia infection were common in this sample of Chinese MSM. Further research is necessary to determine optimal STI screening programs.
Abkürzungen
DHHS
Department of Health and Human Services
LGBT
Lesbian, gay, bisexual, and transgender
MSM
Men who have sex with men
NAAT
Nucleic acid amplification tests
STI
Sexually transmitted infection
STIs
Sexually transmitted infections
TPPA
Treponema pallidum particle agglutination test
TRUST
Toluidine red unheated serum test

Background

Gonorrhea and chlamydia infections are the most common curable sexually transmitted infections (STIs). In 2012 there were an estimated 78 million (53–110 million) new gonorrhea infections and 131 million (100–166 million) chlamydia infections respectively, in 2012 [1]. Men who have sex with men (MSM) have particularly high rates of gonorrhea and chlamydia [27].
Extragenital gonorrhea and chlamydia are major public health problems among MSM. Compared with genital infections, rectal and pharyngeal gonorrhea and chlamydia infections are more likely to be asymptomatic [5] and can easily be missed without screening. Several high-income countries recommend regular screening of extragenital sites (rectum and pharynx) among sexually active MSM [810]. World Health Organization MSM preventive guidelines also support gonorrhea and chlamydia screening among MSM with a higher burden of asymptomatic disease [11]. This suggests the need for research to understand the burden of extragenital gonorrhea and chlamydia among MSM in different settings.
Despite high HIV prevalence and frequent condomless sex among MSM in China, [1218] there are limited data on MSM extragenital gonorrhea and chlamydia. [19, 20] Better understanding the burden of rectal and pharyngeal gonorrhea and chlamydia can provide useful information for research and screening pilots. We undertook this study in Guangzhou, China. Guangzhou is a provincial capital city in south China with a concentrated HIV infection in MSM [21] and a strong STI network. The purpose of this study was to determine the prevalence of gonorrhea and chlamydia at different anatomic sites among MSM in Guangzhou, China.

Methods

Study population and procedure

We recruited a cross-sectional convenience sample of MSM between January 2015 and March 2017. Enrollment criteria included being male, currently living in Guangzhou, being at least 18 years of age, self-identifying as gay or bisexual, and receiving no antibiotics in the past month.
We recruited patients from two clinics at the Dermatology Hospital of Southern Medical University, a tertiary care center with experience serving MSM. The first was an STI clinic run by the hospital, through which any patient who had STI complaints or concerns could request to see a doctor. Patients meeting enrollment criteria who agreed to participate were asked to join the research study. The second was a weekend community clinic sponsored by the Zhitong Guangzhou LGBT (lesbian, gay, bisexual, and transgender) Center, an MSM community organization. This community clinic provides free HIV and syphilis testing services for MSM. During this study, Zhitong also advertised our project on their website and social media account.

Data collection

At enrollment, we collected baseline socio-demographic information, sexual behavior, and STI history. Information about symptoms was collected as a single item. If men had symptoms consistent with an STI, this was noted. There was no effort to attribute symptoms to a particular pathogen in cases of co-infection. All participants underwent physical examination, and any abnormal findings (i.e. warts) were recorded. Urine, rectal and pharyngeal swab samples were collected for gonorrhea and chlamydia testing. Venous blood samples were collected for HIV and syphilis testing. Men with positive tests were treated according to Chinese STI clinical management guidelines.

Laboratory methods

Oropharyngeal, rectal, and urine specimens were tested for gonorrhea and chlamydia using the Cobas 4800 system (Roche Moleculer Systems, Inc. New Jersey, USA). Blood samples were tested for syphilis using a toluidine red unheated serum test (TRUST, Rongsheng Bio-technology Limited Corporation, Shanghai, China) and Treponema pallidum particle agglutination test (TPPA, Fujirebio Inc., Japan). Blood samples were tested for HIV using two antibody tests - a rapid HIV antibody test (Wantai, Beijing, China) and a second antibody test (Abon Biopharm, Hangzhou, China). If both were positive, another blood sample was collected for Western blot confirmation (MP Biomedical, Singapore).
Men were considered infected with gonorrhea and chlamydia if respective tests were positive. Men with positive TRUST and TPPA tests were considered to have syphilis infection, unless a documented history of previously treated syphilis was available. Men with positive HIV screening and confirmatory tests were considered to have HIV infection. Anogenital warts and anogenital herpes were diagnosed according to the diagnostic criteria for China’s notifiable diseases reporting system (Version 2008). These diagnoses are mainly based on exposure history and consistent clinical findings.

Data analysis

We described socio-demographic characteristics, sexual risk behaviors, and STI (by anatomic site) among men. We compared men presenting to the STI clinic and men presenting to the MSM community clinic. Chi-square tests were used to compare gonorrhea/chlamydia prevalence between the STI clinic and MSM community groups. Univariate and multivariate logistic regressions were used to evaluate factors associated gonorrhea and chlamydia, respectively. We also calculated the frequency of men with gonorrhea and chlamydia who were asymptomatic. All data were analyzed using SAS 9.2 (SAS, Cary, USA).
Ethical approval for this study was obtained from the Science Research Ethical Committee of the Dermatology Hospital of Southern Medical University (GDDHLS-201502). Written informed consent was waived because the risk associated with participating in this study was deemed minimal and involved no procedures requiring consent outside of the context of participating in the study. This was approved by the Chinese IRB. It is also in accordance with DHHS (45 CFR 46.117). Verbal consent was obtained before participants were enrolled.

Results

We recruited 463 MSM to join the study. One-hundred and fifty-three men were from the STI clinic and 310 men were from the MSM community clinic. Most men were young, Han ethnicity, unmarried, non-students, and had a higher education level. Socio-demographic characteristics are shown in Table 1.
Table 1
Demographic and behavioral characteristics of participants from the hospital STI clinic and the community-based MSM clinic (n = 463), 2015–2017
 
STI Clinic
n (frequency)
Community clinic
n (frequency)
P-value
Age(years)
  
0.159
< 25
50/153 (32.7%)
128/310 (41.3%)
 
25~35
68/153 (44.4%)
113/310 (36.4%)
 
> 35
35/153 (22.9%)
69/310 (22.3%)
 
Ethnicity
  
0.088
Han
146/153 (95.4%)
282/310 (91.0%)
 
Others
7/153 (4.6%)
28/310 (9.0%)
 
Marital status
  
< 0.0001
Unmarried
101/153 (66.0%)
265/310 (86.6%)
 
Married
50/153 (32.7%)
35/310 (11.4%)
 
Other
2/153 (1.3%)
6/310 (2.0%)
 
Student
  
0.049
Yes
14/153 (9.2%)
49/310 (15.8%)
 
No
139/153 (90.8%)
261/310 (84.2%)
 
Local residence time
  
0.854
0–6 months
22/153 (14.4%)
44/310 (14.5%)
 
6–12 months
9/153 (5.9%)
22/310 (7.3%)
 
Over 1 year
122/153 (79.7%)
237/310 (78.2%)
 
Education level
  
0.065
Junior middle school and below
22/153 (14.4%)
24/310 (7.8%)
 
Senior middle school
22/153 (14.4%)
41/310 (13.2%)
 
Senior middle school above
109/153 (71.2%)
245 (79.0%)
 
Any STI related symptoms
  
< 0.001
 Yes
49/153 (32.0%)
31/310 (10.0%)
 
 No
104/153 (68.0%)
279/310 (90.0%)
 
Condom use in the last 6 months
  
< 0.001
 Any condom less sex
141/153 (92.8)
305/310 (99.3%)
 
 Consistent condom use
11/153 (7.2%)
2/310 (0.7%)
 
Among 463 men, a total of 58 (12.5%) men had gonorrhea infection. The gonorrhea prevalence at urethral, rectal, and pharyngeal sites was 5.2% (24/463), 6.1% (28/463), and 3.9% (18/463), respectively (Table 2). Among all men with gonorrhea, most men (34/58, 59%) did not have STI symptoms. MSM with asymptomatic extragenital gonorrhea were common (Fig. 1). MSM with gonorrhea were more likely to have been recruited from the STI clinic (OR 3.41, 95% CI 1.94–5.99), living with HIV (OR 2.41, 95% CI 1.18–4.92), and diagnosed with STI co-infection (OR 2.55, 95% CI 1.39–4.69) (Table 3).
Table 2
Gonorrhea and chlamydia infection by anatomic sites among 463 MSM in an STI clinic and a community-based clinic in Guangzhou China, 2015–2017
Variables
STI clinic
n (frequency)
Community clinic
n (frequency)
Total
n (frequency)
P*
Gonorrhea
34/153(22.2%)
24/310 (7.7%)
58/463 (12.5%)
< 0.001
 Urethral
22/153 (14.4%)
2/310 (0.7%)
24/463 (5.2%)
< 0.001
 Rectal
11/153 (7.2%)
17/310 (5.5%)
28/463 (6.1%)
0.469
 Pharyngeal
6/153 (3.9%)
12/310 (3.9%)
18/463 (3.9%)
0.979
Chlamydia
29/153 (19.0%)
55/310(17.7%)
84/463 (18.1%)
0.750
 Urethral
18/153 (11.8%)
13/310 (4.2%)
31/463 (6.7%)
0.002
 Rectal
10/153 (6.5%)
42/310 (13.6%)
52/463 (11.2%)
0.025
 Pharyngeal
1/153 (0.7%)
5/310 (1.6%)
6/463 (1.3%)
0.391
HIV
20/153 (13.1%)
40/310 (12.9%)
60/463 (13.0%)
0.959
aOther STIs
49/153 (32.0%)
35/310 (11.3%)
84/463 (18.1%)
< 0.001
*Chi-squared test
aOther STIs refers to syphilis, ano-genital warts and herpes
26 participants were co-infected with gonorrhea and chlamydia
Table 3
Factors associated with gonorrhea and chlamydia infections among 463 MSM in Guangzhou China, 2015–2017
 
gonorrhea(%)
OR (95%CI)
P
AOR
chlamydia(%)
OR(95%CI)
P
AOR
Age(years)
  < 25
26/178 (14.6%)
1.81 (0.81,4.02)
0.148
37/178 (20.8%)
1.34 (0.71,2.53)
0.362
 
 25~35
23/181 (12.7%)
1.54 (0.68,3.46)
0.299
30/181 (16.6%)
1.02 (0.53,1.95)
0.960
 
  > 35
9/104 (8.7%)
1.00
 
17/104 (16.4%)
1.00
  
Ethnicity
 Han
52/428 (12.2%)
0.67(0.27,1.69)
0.394
76/428 (17.8%)
0.73(0.32,1.67)
0.453
 
 Others
6/35 (17.1%)
1.00
 
8/35 (22.9%)
1.00
  
Marital status
 Unmarried
45/366 (12.3%)
0.98(0.12,8.16)
0.986
63/366 (17.2%)
0.62(0.12,3.16)
0.568
 
 Married
12/85 (14.1%)
1.15(0.13,10.20)
0.899
17/85 (20.0%)
0.75(0.14,4.05)
0.737
 
 Other
1/8 (12.5%)
1.00
 
2/8 (25.0%)
1.00
  
Student
 Yes
11/63 (17.5%)
1.59(0.78,3.26)
0.206
17/63 (27.0%)
1.84(0.99,3.39)
0.053
 
 No
47/400 (11.8%)
1.00
 
67/400 (16.8%)
1.00
  
Local residence time
 0–6 months
12/66 (18.2%)
1.59(0.79,3.21)
0.194
12/66 (18.2%)
0.99(0.50,1.95)
0.969
 
 6–12 months
2/31(6.5%%)
0.49(0.11,2.14)
0.346
4/31 (12.9%)
0.66(0.22,1.94)
0.449
 
 Over 1 year
44/359 (12.3%)
1.00
 
66/359 (18.4%)
1.00
  
Education level
 Junior middle school and below
6/46 (13.0%)
1.03(0.41,2.57)
0.949
7/46 (15.2%)
0.74(0.32,1.73)
0.488
 
 Senior middle school
7/63 (11.1%)
0.86(0.39,2.00)
0.723
 
8/63 (12.7%)
0.60(0.27,1.32)
0.204
 
 Senior middle school above
45/354 (12.7%)
1.00
  
69/354 (19.5%)
1.00
  
Recruited from
 STI clinic
34/153 (22.2%)
3.41(1.94,5.99)
< 0.01
2.71(1.49,4.96)
29/153 (19.0%)
1.08(0.66,1.79)
0.750
 Community clinic
24/310 (7.7%)
1.00
 
1.00
55/310 (17.7%)
1.00
 
Any STI related symptoms
 Yes
24/80 (30.0%)
4.40(2.43,7.97)
< 0.01
2.89(1.53,5.47)
20/80 (25.0%)
1.66(0.94,2.95)
0.082
 No
34/383 (8.9%)
1.00
 
1.00
64/383 (16.7%)
1.00
 
Condom use in the last 6 months
 Any condom less sex
56/446 (12.6%)
0.79(0.17,3.66)
0.763
82/446 (18.4%)
1.23(0.27,5.70)
 
 Consistent condom use
2/13 (15.4%)
1.00
 
2/13 (15.4%)
1.00
 
No. of sex partners in last 6 months
1.04(0.94,1.15)
0.424
1.09(1.01,1,18)
0.0495
1.09(1.01,1,18)
HIV positive
 Yes
15/60 (25.0%)
2.79(1.44,5.42)
0.0025
2.41(1.18,4.92)
15/60 (25.0%)
1.61(0.85,3.06)
0.1424
 No
43/403 (10.7%)
1.00
 
1.00
69/403 (17.1%)
1.00
 
Other STIs#
 Yes
19/84 (22.6%)
2.55(1.39,4.69)
0.0026
18/84 (21.4%)
1.29(0.72,2.32)
0.3885
 No
39/379 (10.3%)
1.00
 
66/379 (17.4%)
1.00
 
#: other STIs refers to syphilis, ano-genital warts and ano-genital herpes
A total of 84 men (18.1%) had chlamydia infection at any site. The chlamydia prevalence at the urethral, rectal and oropharyngeal sites was 6.7% (31/463), 11.2% (52/463), and 1.3% (6/463), respectively. Among all men with chlamydia, most men (64/84, 76%) did not have STI symptoms. 61.3% of urethral infections, 83.3% of rectal infections and 83.3% of pharyngeal infections were asymptomatic (Fig. 1). There was a trend towards MSM with chlamydia being more likely to be students (OR 1.8, 95% CI 0.99–3.39).
The chlamydia and gonorrhea coinfection rate was 5.6% (n = 26). Sixty men (13.0%) were living with HIV infection. Eighty-four men (18.1%) had other STIs, including syphilis, anogenital wards, or herpes.

Discussion

Our study evaluated the prevalence of urethral, anal, and pharyngeal gonorrhea and chlamydia among MSM in Guangzhou, China. This study expands the limited literature on MSM extragenital gonorrhea and chlamydia prevalence in an low and middle income country context. This study also compares two different populations of MSM within the same city, providing insight about risk in these groups.
The overall chlamydia prevalence was 18.1%, and the gonorrhea prevalence was 12.5%. The burden of chlamydia and gonorrhea are similar to findings from other Chinese studies in Shenzhen [19] and Kunming [20]. Over half of all STIs were asymptomatic, consistent with other studies. Given that World Health Organization Guidelines recommend MSM screening for asymptomatic urethral and rectal gonorrhea/chlamydia if prevalence is greater than 1–2% [11], our data suggest that screening would be indicated in this population.
We found that the majority of MSM STI infections were asymptomatic. This is consistent with a previous study from the United States [5]. This trend is more pronounced for rectal and pharyngeal infections [22]. The high burden of extra-genital STIs among MSM may help researchers and policy makers making decisions about routine screening guidelines.
Our data suggest that more MSM with symptoms seek care at the STI clinic compared to the MSM community clinic. This is consistent with the STI literature on MSM seeking care at STI clinics compared to community clinics [5]. Asymptomatic infections were especially common in the MSM community clinic. This suggests that asymptomatic screening programs may be more appropriate for MSM community clinics and related settings.
Our study has implications for STI research priorities among MSM. Better understanding the burden of asymptomatic extragenital STIs may be helpful in designing prospective screening studies or modelling research. Despite the fact that many guidelines recommend periodic STI screening among MSM, there are also barriers to screening (cost. Feasibility, logistics). The US Preventive Service Task Force found insufficient evidence to recommend gonorrhea and chlamydia testing among men when it last reviewed the evidence [23]. Accurate assessment of asymptomatic extragenital MSM STIs will also be helpful for the development of local policies and practice guidelines.
Our study has several limitations. First, our study was limited to two clinics taking place in the same hospital in Guangzhou. This study is not representative of MSM in China and caution should be used in making generalizations to other settings. Second, the study was cross-sectional in nature, so we cannot draw conclusions regarding causality. Third, although we asked patients about their symptoms, the main purpose of the survey instrument was not to better understand co-existing symptoms. In addition, symptoms may not have been related to an STI. Pharyngeal symptoms have a wide differential diagnosis, so our estimate of asymptomatic cases of pharyngeal chlamydia and gonorrhea are likely underestimates.

Conclusions

Our findings show that chlamydia and gonorrhea prevalence are high among Chinese MSM. Enhanced screening and treatment of rectal chlamydia and gonorrhea among MSM is necessary to improve sexual health.

Acknowledgements

The authors gratefully acknowledge the support of the Guangzhou LGBT Center and thank the many study participants who made this work possible.

Funding

This work was supported by Medical Science and Technology Foundation of Guangdong Province (C2013010) and Research Fund of the Bureau of Science and Information Technology of Guangzhou Municipality (201704020219). This funding resources had no role in the design of the study and collection, analysis, interpretation of data, and in writing the manuscript.

Availability of data and materials

The original data is available on request to the corresponding author.
Ethical approval for this study was obtained from the Science Research Ethical Committee of the Dermatology Hospital of Southern Medical University (GDDHLS-201502). Written informed consent was waived because the risk associated with participating in this study was deemed minimal and involved no procedures requiring consent outside of the context of participating in the study. This was approved by the Chinese IRB. It is also in accordance with DHHS (45 CFR 46.117). Verbal consent was obtained before participants were enrolled.
Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.CrossRef Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.CrossRef
2.
Zurück zum Zitat Leon SR, Segura ER, Konda KA, Flores JA, Silva-Santisteban A, Galea JT, Coates TJ, Klausner JD, Caceres CF. High prevalence of chlamydia trachomatis and Neisseria gonorrhoeae infections in anal and pharyngeal sites among a community-based sample of men who have sex with men and transgender women in Lima, Peru. BMJ Open. 2016;6(1):e008245.CrossRef Leon SR, Segura ER, Konda KA, Flores JA, Silva-Santisteban A, Galea JT, Coates TJ, Klausner JD, Caceres CF. High prevalence of chlamydia trachomatis and Neisseria gonorrhoeae infections in anal and pharyngeal sites among a community-based sample of men who have sex with men and transgender women in Lima, Peru. BMJ Open. 2016;6(1):e008245.CrossRef
3.
Zurück zum Zitat Tongtoyai J, Todd CS, Chonwattana W, Pattanasin S, Chaikummao S, Varangrat A, Lokpichart S, Holtz TH, van Griensven F, Curlin ME. Prevalence and correlates of chlamydia trachomatis and Neisseria gonorrhoeae by anatomic site among urban Thai men who have sex with men. Sex Transm Dis. 2015;42(8):440–9.CrossRef Tongtoyai J, Todd CS, Chonwattana W, Pattanasin S, Chaikummao S, Varangrat A, Lokpichart S, Holtz TH, van Griensven F, Curlin ME. Prevalence and correlates of chlamydia trachomatis and Neisseria gonorrhoeae by anatomic site among urban Thai men who have sex with men. Sex Transm Dis. 2015;42(8):440–9.CrossRef
4.
Zurück zum Zitat Vodstrcil LA, Fairley CK, Fehler G, Leslie D, Walker J, Bradshaw CS, Hocking JS. Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009. BMC Infect Dis. 2011;11:158.CrossRef Vodstrcil LA, Fairley CK, Fehler G, Leslie D, Walker J, Bradshaw CS, Hocking JS. Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009. BMC Infect Dis. 2011;11:158.CrossRef
5.
Zurück zum Zitat Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, Klausner JD. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67–74.CrossRef Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, Klausner JD. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67–74.CrossRef
6.
Zurück zum Zitat Rebe K, Lewis D, Myer L, de Swardt G, Struthers H, Kamkuemah M, McIntyre J. A Cross Sectional Analysis of gonococcal and chlamydial infections among men-who-have-sex-with-men in Cape Town, South Africa. PLoS One. 2015;10(9):e0138315.CrossRef Rebe K, Lewis D, Myer L, de Swardt G, Struthers H, Kamkuemah M, McIntyre J. A Cross Sectional Analysis of gonococcal and chlamydial infections among men-who-have-sex-with-men in Cape Town, South Africa. PLoS One. 2015;10(9):e0138315.CrossRef
7.
Zurück zum Zitat Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U. Group Ps: prevalence of pharyngeal and rectal chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect. 2014;90(1):46–51.CrossRef Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U. Group Ps: prevalence of pharyngeal and rectal chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect. 2014;90(1):46–51.CrossRef
8.
Zurück zum Zitat Workowski KA. Bolan GA, centers for disease C, prevention: sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.PubMedPubMedCentral Workowski KA. Bolan GA, centers for disease C, prevention: sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.PubMedPubMedCentral
9.
Zurück zum Zitat Bourne C, Edwards B, Shaw M, Gowers A, Rodgers C, Ferson M. Sexually transmissible infection testing guidelines for men who have sex with men. Sex Health. 2008;5(2):189–91.CrossRef Bourne C, Edwards B, Shaw M, Gowers A, Rodgers C, Ferson M. Sexually transmissible infection testing guidelines for men who have sex with men. Sex Health. 2008;5(2):189–91.CrossRef
10.
Zurück zum Zitat Patel RR, Patel S, Clarke E, Khan AW, Doshi B, Radcliffe KW. European collaborative clinical G: guidance and practice on frequency of HIV and sexually transmitted infection testing in men who have sex with men - what is the European situation? Int J STD AIDS. 2014;25(3):213–8.CrossRef Patel RR, Patel S, Clarke E, Khan AW, Doshi B, Radcliffe KW. European collaborative clinical G: guidance and practice on frequency of HIV and sexually transmitted infection testing in men who have sex with men - what is the European situation? Int J STD AIDS. 2014;25(3):213–8.CrossRef
11.
Zurück zum Zitat Gerbase A. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender People: Recommendations for a public health approach. Geneva: WHO, Programme HIV/AIDS; 2011. Report No.: ISBN 978 92 4 150175 0. Gerbase A. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender People: Recommendations for a public health approach. Geneva: WHO, Programme HIV/AIDS; 2011. Report No.: ISBN 978 92 4 150175 0.
12.
Zurück zum Zitat Dai W, Luo Z, Xu R, Zhao G, Tu D, Yang L, Wang F, Cai Y, Lan L, Hong F, et al. Prevalence of HIV and syphilis co-infection and associated factors among non-commercial men who have sex with men attending a sexually transmitted disease clinic in Shenzhen, China. BMC Infect Dis. 2017;17(1):86.CrossRef Dai W, Luo Z, Xu R, Zhao G, Tu D, Yang L, Wang F, Cai Y, Lan L, Hong F, et al. Prevalence of HIV and syphilis co-infection and associated factors among non-commercial men who have sex with men attending a sexually transmitted disease clinic in Shenzhen, China. BMC Infect Dis. 2017;17(1):86.CrossRef
13.
Zurück zum Zitat Zhao J, Chen L, Chaillon A, Zheng C, Cai W, Yang Z, Li G, Gan Y, Wang X, Hu Y, et al. The dynamics of the HIV epidemic among men who have sex with men (MSM) from 2005 to 2012 in Shenzhen, China. Sci Rep. 2016;6:28703.CrossRef Zhao J, Chen L, Chaillon A, Zheng C, Cai W, Yang Z, Li G, Gan Y, Wang X, Hu Y, et al. The dynamics of the HIV epidemic among men who have sex with men (MSM) from 2005 to 2012 in Shenzhen, China. Sci Rep. 2016;6:28703.CrossRef
14.
Zurück zum Zitat Zeng X, Zhong X, Peng B, Zhang Y, Kong C, Liu X, Huang A. Prevalence and associated risk characteristics of HIV infection based on anal sexual role among men who have sex with men: a multi-city cross-sectional study in Western China. Int J Infect Dis. 2016;49:111–8.CrossRef Zeng X, Zhong X, Peng B, Zhang Y, Kong C, Liu X, Huang A. Prevalence and associated risk characteristics of HIV infection based on anal sexual role among men who have sex with men: a multi-city cross-sectional study in Western China. Int J Infect Dis. 2016;49:111–8.CrossRef
15.
Zurück zum Zitat Yang Z, Huang Z, Dong Z, Li J, Zhang S, Wu N, Jin M. Risk factors for HIV diagnosis among men who have sex with men: results of a case-control study in one sample of eastern China. AIDS Res Hum Retrovir. 2016;32(12):1163–8.CrossRef Yang Z, Huang Z, Dong Z, Li J, Zhang S, Wu N, Jin M. Risk factors for HIV diagnosis among men who have sex with men: results of a case-control study in one sample of eastern China. AIDS Res Hum Retrovir. 2016;32(12):1163–8.CrossRef
16.
Zurück zum Zitat Li R, Wang H, Pan X, Ma Q, Chen L, Zhou X, Jiang T, He L, Chen J, Zhang X, et al. Prevalence of condomless anal intercourse and recent HIV testing and their associated factors among men who have sex with men in Hangzhou, China: a respondent-driven sampling survey. PLoS One. 2017;12(3):e0167730.CrossRef Li R, Wang H, Pan X, Ma Q, Chen L, Zhou X, Jiang T, He L, Chen J, Zhang X, et al. Prevalence of condomless anal intercourse and recent HIV testing and their associated factors among men who have sex with men in Hangzhou, China: a respondent-driven sampling survey. PLoS One. 2017;12(3):e0167730.CrossRef
17.
Zurück zum Zitat Qin Q, Tang W, Ge L, Li D, Mahapatra T, Wang L, Guo W, Cui Y, Sun J. Changing trend of HIV, syphilis and hepatitis C among men who have sex with men in China. Sci Rep. 2016;6:31081.CrossRef Qin Q, Tang W, Ge L, Li D, Mahapatra T, Wang L, Guo W, Cui Y, Sun J. Changing trend of HIV, syphilis and hepatitis C among men who have sex with men in China. Sci Rep. 2016;6:31081.CrossRef
18.
Zurück zum Zitat Qin Q, Guo W, Tang W, Mahapatra T, Wang L, Zhang N, Ding Z, Cai C, Cui Y, Sun J. Spatial analysis of the human immunodeficiency virus epidemic among men who have sex with men in China, 2006-2015. Clin Infect Dis. 2017;64(7):956–63.CrossRef Qin Q, Guo W, Tang W, Mahapatra T, Wang L, Zhang N, Ding Z, Cai C, Cui Y, Sun J. Spatial analysis of the human immunodeficiency virus epidemic among men who have sex with men in China, 2006-2015. Clin Infect Dis. 2017;64(7):956–63.CrossRef
19.
Zurück zum Zitat Li JH, Cai YM, Yin YP, Hong FC, Shi MQ, Feng TJ, Peng RR, Wang BX, Chen XS. Prevalence of anorectal chlamydia trachomatis infection and its genotype distribution among men who have sex with men in Shenzhen, China. Jpn J Infect Dis. 2011;64(2):143–6.PubMed Li JH, Cai YM, Yin YP, Hong FC, Shi MQ, Feng TJ, Peng RR, Wang BX, Chen XS. Prevalence of anorectal chlamydia trachomatis infection and its genotype distribution among men who have sex with men in Shenzhen, China. Jpn J Infect Dis. 2011;64(2):143–6.PubMed
20.
Zurück zum Zitat Zhang X, Jia M, Chen M, Luo H, Chen H, Luo W, Zhang W, Ma Y, Yang C, Yang Y, et al. Prevalence and the associated risk factors of HIV, STIs and HBV among men who have sex with men in Kunming, China. Int J STD AIDS. 2017;28(11):1115–23.CrossRef Zhang X, Jia M, Chen M, Luo H, Chen H, Luo W, Zhang W, Ma Y, Yang C, Yang Y, et al. Prevalence and the associated risk factors of HIV, STIs and HBV among men who have sex with men in Kunming, China. Int J STD AIDS. 2017;28(11):1115–23.CrossRef
21.
Zurück zum Zitat Zhong F, Liang B, Xu H, Cheng W, Fan L, Han Z, Liang C, Gao K, Mai H, Qin F, et al. Increasing HIV and decreasing syphilis prevalence in a context of persistently high unprotected anal intercourse, six consecutive annual surveys among men who have sex with men in Guangzhou, China, 2008 to 2013. PLoS One. 2014;9(7):e103136.CrossRef Zhong F, Liang B, Xu H, Cheng W, Fan L, Han Z, Liang C, Gao K, Mai H, Qin F, et al. Increasing HIV and decreasing syphilis prevalence in a context of persistently high unprotected anal intercourse, six consecutive annual surveys among men who have sex with men in Guangzhou, China, 2008 to 2013. PLoS One. 2014;9(7):e103136.CrossRef
22.
Zurück zum Zitat Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ. Extragenital infections caused by chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;2016:5758387.CrossRef Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ. Extragenital infections caused by chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;2016:5758387.CrossRef
23.
Zurück zum Zitat LeFevre ML, Force USPST. Screening for chlamydia and gonorrhea: U.S. preventive services task Force recommendation statement. Ann Intern Med. 2014;161(12):902–10.CrossRef LeFevre ML, Force USPST. Screening for chlamydia and gonorrhea: U.S. preventive services task Force recommendation statement. Ann Intern Med. 2014;161(12):902–10.CrossRef
Metadaten
Titel
Gonorrhea and chlamydia prevalence in different anatomical sites among men who have sex with men: a cross-sectional study in Guangzhou, China
verfasst von
Li-Gang Yang
Xiao-Hui Zhang
Pei-Zhen Zhao
Zheng-Yu Chen
Wu-Jian Ke
Xu-Qi Ren
Liu-Yuan Wang
Wei-Ying Chen
Joseph D. Tucker
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2018
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3579-6

Weitere Artikel der Ausgabe 1/2018

BMC Infectious Diseases 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.